Widening use of dexamethasone implant for the treatment of macular edema

Sustained-release intravitreal 0.7 mg dexamethasone (DEX) implant is approved in Europe for the treatment of macular edema related to diabetic retinopathy, branch retinal vein occlusion, central retinal vein occlusion, and non-infectious uveitis. The implant is formulated in a biodegradable copolyme...

Full description

Saved in:
Bibliographic details
Volume: 11
Main Author: Bonfiglio, Vincenza
Reibaldi, Michele
Fallico, Matteo
Russo, Andrea
Pizzo, Alessandra
Fichera, Stefano
Rapisarda, Carlo
Macchi, Iacopo
Avitabile, Teresio
Longo, Antonio
Format: Journal Article
Language: English
Zielgruppe: Academic
Place of publication: ALBANY DOVE MEDICAL PRESS LTD 01.01.2017
Dove Medical Press Limited
Dove Medical Press
published in: Drug design, development and therapy Vol. 11; pp. 2359 - 2372
Data of publication: 2017-01-01
ISSN: 1177-8881
1177-8881
EISSN: 1177-8881
Discipline: Pharmacy, Therapeutics, & Pharmacology
Subjects:
Online Access: Fulltext
Database: Web of Science - Science Citation Index Expanded - 2017
Web of Knowledge
Science Citation Index Expanded
Web of Science
MEDLINE (Ovid)
PubMed
MEDLINE
MEDLINE
MEDLINE
Medline
CrossRef
MEDLINE - Academic
Directory of Open Access Journals
Database information Databases - DBIS